Alpha-1 antitrypsin in autoimmune diseases: Roles and therapeutic prospects
Sun R, Xu Z, Zhu C, Chen T, Munoz LE, Dai L, Zhao Y (2022)
Publication Type: Journal article
Publication year: 2022
Journal
Book Volume: 110
DOI: 10.1016/j.intimp.2022.109001
Abstract
Alpha-1 antitrypsin (A1AT) is a protease inhibitor in the serum. Its primary function is to inhibit the activity of a series of proteases, including proteinase 3, neutrophil elastase, metalloproteases, and cysteine-aspartate proteases. In addition, A1AT also has anti-inflammatory, anti-apoptotic, anti-oxidative stress, anti-viral, and antibacterial activities and plays essential roles in the regulation of tissue repair and lymphocyte differentiation and activation. The overactivation of the immune system characterizes the pathogenesis of autoimmune diseases. A1AT treatment shows beneficial effects on patients and animal models with autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus. This review summarizes the functions and therapeutic prospects of A1AT in autoimmune diseases.
Authors with CRIS profile
Involved external institutions
China (CN)How to cite
APA:
Sun, R., Xu, Z., Zhu, C., Chen, T., Munoz, L.E., Dai, L., & Zhao, Y. (2022). Alpha-1 antitrypsin in autoimmune diseases: Roles and therapeutic prospects. International Immunopharmacology, 110. https://doi.org/10.1016/j.intimp.2022.109001
MLA:
Sun, Rui, et al. "Alpha-1 antitrypsin in autoimmune diseases: Roles and therapeutic prospects." International Immunopharmacology 110 (2022).
BibTeX: Download